Stuart J Connolly Selected Research

celivarone

5/2012	Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
2/2012	Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions.
12/2011	Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart J Connolly Research Topics

Disease

144	Atrial Fibrillation 09/2022 - 04/2002
127	Stroke (Strokes) 12/2022 - 01/2003
94	Hemorrhage 11/2022 - 03/2003
48	Embolism (Embolus) 01/2022 - 11/2006
30	Myocardial Infarction 12/2022 - 03/2003
30	Heart Failure 09/2022 - 01/2005
25	Ischemic Stroke 01/2021 - 11/2011
17	Peripheral Arterial Disease 12/2022 - 01/2017
17	Embolic Stroke 01/2022 - 04/2014
14	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 11/2006
14	Cardiac Arrhythmias (Arrythmia) 12/2019 - 03/2003
12	Atrial Flutter (Flutter, Atrial) 01/2021 - 04/2002
11	Thrombosis (Thrombus) 01/2022 - 02/2013
11	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 03/2011
9	Infections 11/2021 - 07/2010
9	Hypertension (High Blood Pressure) 01/2021 - 01/2005
8	Vascular Diseases (Vascular Disease) 10/2022 - 06/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2008
6	Atherosclerosis 01/2022 - 01/2019
6	Diabetes Mellitus 01/2020 - 10/2014
5	Ischemia 12/2020 - 11/2011
5	Transient Ischemic Attack 08/2019 - 11/2006
5	Ventricular Tachycardia 10/2015 - 04/2002
5	Syncope (Fainting) 05/2012 - 05/2003
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2021 - 02/2014
4	Hemorrhagic Stroke 04/2021 - 09/2009
4	Left Ventricular Dysfunction 01/2020 - 11/2006
4	Shock 01/2019 - 01/2006
4	Heart Arrest (Cardiac Arrest) 10/2015 - 12/2003
4	Acute Coronary Syndrome 02/2014 - 10/2010
3	Bradycardia 02/2022 - 01/2006
3	Hematoma 01/2022 - 03/2009
3	Brain Infarction 10/2020 - 09/2016
3	Infarction (Infarctions) 10/2020 - 08/2019
3	Thromboembolism 01/2019 - 03/2015
3	Unstable Angina 01/2018 - 02/2012
3	Pulmonary Embolism 12/2015 - 02/2012
3	Chronic Renal Insufficiency 03/2014 - 10/2011
3	Vasovagal Syncope 10/2009 - 05/2003
2	Venous Thromboembolism 01/2022 - 01/2018
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Cerebral Hemorrhage 01/2022 - 01/2021
2	Heart Valve Diseases (Valvular Heart Disease) 12/2021 - 08/2016
2	Cognitive Dysfunction 10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

66	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 03/2003
59	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 03/2003
48	Dabigatran FDA Link 07/2019 - 09/2009
46	AnticoagulantsIBA 04/2022 - 05/2003
45	RivaroxabanIBA 12/2022 - 05/2014
25	Vitamin K FDA Link 01/2022 - 05/2009
22	apixabanIBA 06/2022 - 03/2010
17	Clopidogrel (Plavix)FDA Link 01/2018 - 03/2003
15	Factor Xa InhibitorsIBA 01/2022 - 03/2010
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2012
14	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 01/2016
13	Dronedarone FDA Link 12/2014 - 09/2007
12	Irbesartan FDA LinkGeneric 01/2018 - 09/2003
10	Pharmaceutical PreparationsIBA 01/2020 - 03/2003
10	Anti-Arrhythmia AgentsIBA 02/2014 - 04/2002
8	PRT064445IBA 06/2022 - 01/2016
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2012
7	CreatinineIBA 01/2022 - 02/2009
5	Hemostatics (Antihemorrhagics)IBA 06/2022 - 02/2013
5	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2022 - 08/2009
5	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2012
5	Amiodarone (Amiodarona)FDA LinkGeneric 12/2011 - 03/2003
5	azimilideIBA 07/2006 - 04/2002
4	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2018
4	bucindololIBA 02/2022 - 01/2018
4	Troponin T (Troponin T1)IBA 01/2022 - 06/2016
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 09/2009
3	AntidotesIBA 01/2022 - 07/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2020 - 12/2018
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 10/2014
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2019 - 03/2009
3	Troponin IIBA 01/2019 - 04/2012
3	Heparin (Liquaemin)FDA LinkGeneric 11/2018 - 06/2017
3	TroponinIBA 11/2016 - 12/2015
3	Cystatin CIBA 06/2016 - 03/2014
3	AntithrombinsIBA 09/2013 - 03/2003
3	celivaroneIBA 05/2012 - 12/2011
3	DiamondIBA 02/2007 - 07/2005
2	edoxabanIBA 06/2022 - 09/2010
2	Prothrombin (Factor II)IBA 04/2022 - 01/2022
2	prothrombin complex concentrates (PPSB)IBA 01/2022 - 01/2022
2	Trefoil Factor-3IBA 01/2022 - 12/2020
2	Cefazolin (Ancef)FDA LinkGeneric 11/2021 - 12/2018
2	N(4)-oleylcytosine arabinosideIBA 01/2021 - 01/2017

Therapy/Procedure

103	Therapeutics 10/2022 - 03/2003
17	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 09/2020 - 12/2003
12	Defibrillators (Defibrillator) 12/2018 - 12/2003
9	Secondary Prevention 09/2020 - 05/2003
6	Surgical Amputation (Amputations) 01/2020 - 11/2013
5	Electric Countershock (Cardioversion) 01/2021 - 01/2005
3	Cardiac Resynchronization Therapy 01/2014 - 07/2010
2	Anticoagulation Reversal 06/2022 - 01/2021
2	Transitional Care 11/2021 - 01/2019
2	Contraindications 01/2021 - 01/2019
2	Catheter Ablation 01/2021 - 12/2012